贝达药业：目前公司经营正常

Core Viewpoint - The company has scheduled the disclosure date for its 2025 annual report as April 23, 2026, based on the progress of its business operations [1] Group 1 - The company confirmed that its operations are currently normal [1] - The company advised that information regarding its 2025 operating performance will be disclosed publicly [1]